reAlpha Tech is trading 9.01% down at $0.35 in pre-market, with no clear overnight catalyst identified.

  • Shareholders approved a discretionary reverse-split authorization, at a ratio from 1-for-2 to 1-for-50, at the November 5 annual meeting.
  • The approval was reported in a November 6 SEC filing; available reporting does not establish it as the cause of the pre-market decline.
  • Major U.S. indices were modestly higher in the supplied market context.